AHA 2024: GLP-1, SGLT2 Treatments May Lower Risk of Future Heart Attack, Stroke for Stroke Survivors
New data presented at the American Heart Association (AHA) 2024 Scientific Sessions suggest that stroke survivors taking either a glucagon-like peptide-1 (GLP-1) receptor agonist or a sodium-glucose cotransporter-2 (SGLT2) inhibitor had a lower risk of a …